Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorAssiut University
About this trial
The association of metabolic associated fatty liver disease in patients with chronic glomerular disease
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All CKD patient aging between (18-70) years with known tubule-glomerular diseases.
At any eGFR.
All CKD patient have either type I/II DM associated with CKD .
Disqualifiers
CKD patients of Unknown etiology.
CKD patients with liver cirrhosis.
CKD patients secondry to documented diabetic nephropathy.
Patients with previous/current HBV or HCV.
Trial population
All patients in this study will be subjected to 1. Detailed history and full clinical examination 2. Anthropometric measurements; Hight, weight, waist circumference. 3. Full lab investigations (Complete blood picture , kidney function tests, liver function tests, serum electrolytes, Ferritin, Uric acid level, Prothrombin time and concentration and serum albumin) 4. High sensitivity CRP 5. lipid profile (Fasting) 6. urine analysis, ACR. 7. Available documented renal biopsy 8. HBA1c 9. C- peptide levels. 10. FIB4 - score
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
500 Participants
are grouped into 1 trial groupGroup A: study group
Trial outcomes
Primary outcomes
1
association between metabolic associated fatty liver disease and chronic kidney disease
To detect the association between metabolic associated fatty liver disease and chronic kidney disease with glomerular diseaese in Assuit university hospital.
Time frame
through study completion, an average of 1 yearLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: